<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1E482C41-09A4-4F85-92ED-81B209D7F872"><gtr:id>1E482C41-09A4-4F85-92ED-81B209D7F872</gtr:id><gtr:name>Austrian Centre of Industrial Biotechnology</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/82200E1A-04DA-42F5-80F3-B0FF026643BD"><gtr:id>82200E1A-04DA-42F5-80F3-B0FF026643BD</gtr:id><gtr:name>University of Copenhagen</gtr:name><gtr:address><gtr:line1>Norregade 10</gtr:line1><gtr:line2>Postboks 2177</gtr:line2><gtr:line4>Copenhagen K</gtr:line4><gtr:line5>DK-1017</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F649AB83-DC92-4360-807F-BBFEF0DE8EE4"><gtr:id>F649AB83-DC92-4360-807F-BBFEF0DE8EE4</gtr:id><gtr:name>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A9488014-F393-4296-912D-26AE4100E967"><gtr:id>A9488014-F393-4296-912D-26AE4100E967</gtr:id><gtr:name>Austrian Centre for Applied Biotechnology</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/B52848EB-6923-4123-A367-0D33966FD9FC"><gtr:id>B52848EB-6923-4123-A367-0D33966FD9FC</gtr:id><gtr:name>Albert-Ludwigs University Freiburg</gtr:name><gtr:address><gtr:line1>Albert-Ludwigs University</gtr:line1><gtr:line2>Werthmannplatz 1</gtr:line2><gtr:line3>D-79085 Freiburg1</gtr:line3><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:department>Sch of Chemistry</gtr:department><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1E482C41-09A4-4F85-92ED-81B209D7F872"><gtr:id>1E482C41-09A4-4F85-92ED-81B209D7F872</gtr:id><gtr:name>Austrian Centre of Industrial Biotechnology</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/82200E1A-04DA-42F5-80F3-B0FF026643BD"><gtr:id>82200E1A-04DA-42F5-80F3-B0FF026643BD</gtr:id><gtr:name>University of Copenhagen</gtr:name><gtr:address><gtr:line1>Norregade 10</gtr:line1><gtr:line2>Postboks 2177</gtr:line2><gtr:line4>Copenhagen K</gtr:line4><gtr:line5>DK-1017</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Denmark</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F649AB83-DC92-4360-807F-BBFEF0DE8EE4"><gtr:id>F649AB83-DC92-4360-807F-BBFEF0DE8EE4</gtr:id><gtr:name>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A9488014-F393-4296-912D-26AE4100E967"><gtr:id>A9488014-F393-4296-912D-26AE4100E967</gtr:id><gtr:name>Austrian Centre for Applied Biotechnology</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/B52848EB-6923-4123-A367-0D33966FD9FC"><gtr:id>B52848EB-6923-4123-A367-0D33966FD9FC</gtr:id><gtr:name>Albert-Ludwigs University Freiburg</gtr:name><gtr:address><gtr:line1>Albert-Ludwigs University</gtr:line1><gtr:line2>Werthmannplatz 1</gtr:line2><gtr:line3>D-79085 Freiburg1</gtr:line3><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CE8DA1F4-C27B-41D3-9F03-2A183EA393F3"><gtr:id>CE8DA1F4-C27B-41D3-9F03-2A183EA393F3</gtr:id><gtr:name>CNRS</gtr:name><gtr:address><gtr:line1>1919 Route de Mende</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/B673D122-79F7-4409-AA5F-9130CFB538A4"><gtr:id>B673D122-79F7-4409-AA5F-9130CFB538A4</gtr:id><gtr:name>Austrian Centre of Industrial Biotech</gtr:name><gtr:address><gtr:line1>Petersgasse 14</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/59164F2A-D253-4EDC-B4C3-483FBD27D087"><gtr:id>59164F2A-D253-4EDC-B4C3-483FBD27D087</gtr:id><gtr:firstName>Emanuele</gtr:firstName><gtr:surname>Paci</gtr:surname><gtr:orcidId>0000-0002-4891-2768</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/65CE5252-E2A5-4C43-AEAB-C537D2C950D1"><gtr:id>65CE5252-E2A5-4C43-AEAB-C537D2C950D1</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>Edward</gtr:otherNames><gtr:surname>Webb</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/57370672-5FC3-4C5D-932D-6D3865E4B2FD"><gtr:id>57370672-5FC3-4C5D-932D-6D3865E4B2FD</gtr:id><gtr:firstName>Bruce</gtr:firstName><gtr:surname>Turnbull</gtr:surname><gtr:orcidId>0000-0002-7352-0360</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FM005666%2F1"><gtr:id>F5C8136A-C821-46F1-B80D-B1664B099A73</gtr:id><gtr:title>14-ERASynBio: Synthetic Glycobiology - new strategies to build and functionalise proto-cells and proto-tissues</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/M005666/1</gtr:grantReference><gtr:abstractText>Great advances have been made in the development of proto-cells based on giant unilamellar vesicles (GUVs). However, one essential functional element of all living cells still to be incorporated into such systems is a glycocalyx. This coating of complex carbohydrates extends up to 100 nm from the cell membrane and provides an adhesive layer that mediates interactions between different cell types, viruses and signalling molecules. In most cases, these interactions involve specific carbohydrate-binding proteins (lectins) which may be either soluble or membrane-bound. For example, fertilisation is initiated by a specific carbohydrate on the surface of the egg adhering to a specific lectin on the head of the sperm. Protein-carbohydrate interactions also mediate the endocytosis of many bacteria, viruses and bacterial toxins which stick to specific glycolipids on the cell membrane. Protein-carbohydrate interactions thus present a general strategy for enabling cell adhesion and cell entry. In this project we will design and create a modular toolbox of synthetic glcocalyx components and engineered lectins that will be attached to lipid membranes to enable reversible proto-cell adhesion and incorporated into virus-like particles to mediate proto-cell entry. The methodology will be exemplified through the construction of proto-cells that contain &amp;quot;proto-organelles&amp;quot; and the assembly and remodelling of &amp;quot;proto-tissues&amp;quot; in which multiple types of proto-cells are brought together in a pre-defined fashion to create more complex systems.</gtr:abstractText><gtr:technicalSummary>Great advances have been made in the development of proto-cells based on giant unilamellar vesicles (GUVs). However, one essential functional element of all living cells still to be incorporated into such systems is a glycocalyx. This coating of complex carbohydrates extends up to 100 nm from the cell membrane and provides an adhesive layer that mediates interactions between different cell types, viruses and signalling molecules. In most cases, these interactions involve specific carbohydrate-binding proteins (lectins) which may be either soluble or membrane-bound. For example, fertilisation is initiated by a specific carbohydrate on the surface of the egg adhering to a specific lectin on the head of the sperm. Protein-carbohydrate interactions also mediate the endocytosis of many bacteria, viruses and bacterial toxins which stick to specific glycolipids on the cell membrane. Protein-carbohydrate interactions thus present a general strategy for enabling cell adhesion and cell entry. In this project we will design and create a modular toolbox of synthetic glcocalyx components and engineered lectins that will be attached to lipid membranes to enable reversible proto-cell adhesion and incorporated into virus-like particles to mediate proto-cell entry. The methodology will be exemplified through the construction of proto-cells that contain &amp;quot;proto-organelles&amp;quot; and the assembly and remodelling of &amp;quot;proto-tissues&amp;quot; in which multiple types of proto-cells are brought together in a pre-defined fashion to create more complex systems.</gtr:technicalSummary><gtr:potentialImpactText>In the longer term, the neolectins, superlectins, virus-like particles and lectin-modified proto-cells will provide tools for delivering macromolecular drugs in a cell-specific fashion. At present most of the biopharmaceuticals on the market recognise cell surface targets, but the neolectins etc, will provide a mechanism for delivery into cells by endocytosis, and potentially intracellular trafficking to defined organelles. This advance will expand the range of medical targets accessible to biopharmaceuticals, while helping to reduce the high doses necessary for novel treatments that already act intracellularly, e.g., exon-skipping RNA based drugs. Applicant Turnbull already collaborates with GSK on macromolecular drug delivery using lectins. He also leads the targeted delivery theme of the University of Leeds Pharmaceutical and Biopharmaceutical Industry Hub which fosters translational collaborations between academic and industrial partners. Furthermore, the involvement of applicant Wiltschi from the Austrian Centre of Industrial Biotechnology (ACIB) will provide another key pathway to achieving impact from our research. The ACIB has 30 company partners and will function as a hub for the dissemination of results to potential industrial partners and the translational development of products involving neolectins and superlectins developed in SYNGLYCTIS. 
Through this proposal we will contribute to the training of skilled individuals (including 8 early stage researchers) who will gain expertise in design, engineering and characterisation of protein and lipid assemblies for synthetic biology applications. The provision of skilled workers who are empowered to contribute to the development of both academic and industrial synthetic biology will have long term societal benefit for Europe. Their work in this project and through the rest of their careers will lead to new diagnostic methods and clinical treatments that will improve the health and quality of life for millions of Europeans.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-11-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2014-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>636759</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Austrian Centre for Applied Biotechnology</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:description>SynGlycTis network</gtr:description><gtr:id>41EFE0D5-8707-4D0D-8ED8-B9AC3066FDC3</gtr:id><gtr:impact>Outputs ongoing. Collaboration brings together chemists, structural biologists, protein engineers, cell biologists.</gtr:impact><gtr:partnerContribution>Expertise in introducing non-canonical amino acids into proteins transferred to Leeds from AICB
Samples from Leeds evaluated in giant unilamellar vesicle experiments at University of Freiburg</gtr:partnerContribution><gtr:piContribution>We have provided expertise in protein modification and samples for testing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Austrian Centre of Industrial Biotechnology</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:description>SynGlycTis</gtr:description><gtr:id>0F406084-A22E-46BE-B84C-1206CC9F01C5</gtr:id><gtr:impact>new methods for formation of prototissues and delivery of quantum dots into brain cells</gtr:impact><gtr:partnerContribution>Providing detailed research methodologies and hosting researchers to perform specific experiments</gtr:partnerContribution><gtr:piContribution>Sharing of facilities, samples and expertise</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Copenhagen</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:description>SynGlycTis</gtr:description><gtr:id>FEBFF5B9-2D69-4CC8-A9E2-F04237282A06</gtr:id><gtr:impact>new methods for formation of prototissues and delivery of quantum dots into brain cells</gtr:impact><gtr:partnerContribution>Providing detailed research methodologies and hosting researchers to perform specific experiments</gtr:partnerContribution><gtr:piContribution>Sharing of facilities, samples and expertise</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Freiburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Centre for Biological Signalling Studies (BIOSS)</gtr:department><gtr:description>SynGlycTis network</gtr:description><gtr:id>91520D5B-12FE-4663-BAF3-AB924FA3A7A9</gtr:id><gtr:impact>Outputs ongoing. Collaboration brings together chemists, structural biologists, protein engineers, cell biologists.</gtr:impact><gtr:partnerContribution>Expertise in introducing non-canonical amino acids into proteins transferred to Leeds from AICB
Samples from Leeds evaluated in giant unilamellar vesicle experiments at University of Freiburg</gtr:partnerContribution><gtr:piContribution>We have provided expertise in protein modification and samples for testing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Freiburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>SynGlycTis</gtr:description><gtr:id>2E3F9107-C994-45BF-91EF-C7ED4BFE9979</gtr:id><gtr:impact>new methods for formation of prototissues and delivery of quantum dots into brain cells</gtr:impact><gtr:partnerContribution>Providing detailed research methodologies and hosting researchers to perform specific experiments</gtr:partnerContribution><gtr:piContribution>Sharing of facilities, samples and expertise</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Copenhagen</gtr:collaboratingOrganisation><gtr:country>Denmark, Kingdom of</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>SynGlycTis network</gtr:description><gtr:id>923B2466-2112-4C33-8371-FD44EAA9B870</gtr:id><gtr:impact>Outputs ongoing. Collaboration brings together chemists, structural biologists, protein engineers, cell biologists.</gtr:impact><gtr:partnerContribution>Expertise in introducing non-canonical amino acids into proteins transferred to Leeds from AICB
Samples from Leeds evaluated in giant unilamellar vesicle experiments at University of Freiburg</gtr:partnerContribution><gtr:piContribution>We have provided expertise in protein modification and samples for testing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>SynGlycTis network</gtr:description><gtr:id>6AA03176-473D-45D1-BC98-DB44BE887651</gtr:id><gtr:impact>Outputs ongoing. Collaboration brings together chemists, structural biologists, protein engineers, cell biologists.</gtr:impact><gtr:partnerContribution>Expertise in introducing non-canonical amino acids into proteins transferred to Leeds from AICB
Samples from Leeds evaluated in giant unilamellar vesicle experiments at University of Freiburg</gtr:partnerContribution><gtr:piContribution>We have provided expertise in protein modification and samples for testing</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>BioLeeds</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BF5BA664-E96C-4607-9578-594C73D3BDD9</gtr:id><gtr:impact>Collaboration with a group of artists to produce an exhibition for engaging the general public in glycoscience</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Reengineering Bacterial Toxins for New Purposes</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6A1B588F-AAE6-44EB-A593-31F123559CA2</gtr:id><gtr:impact>dissemination of results at international conferences</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015,2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Complex Life of Sugars</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>27D28614-0E09-4224-BFE7-BAEE98845178</gtr:id><gtr:impact>stimulated the public's awareness of the importance of glycoscience

enthused several of my students to participate in further outreach eevnts</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Understanding, Inhibiting and Exploiting Bacterial Toxins</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9E1D43FB-5054-4450-8EA1-FACD55627721</gtr:id><gtr:impact>A research talk outlining the methods we have developed to make site specific chemical modifications on bacterial toxins.

further invitations to talk and to participate in grant applications</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011,2012,2013,2014,2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>5200</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC Impact Acceleration Account</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>BBE5FBEA-D48B-4F4C-9611-CD9606B97276</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15999</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Follow on Fund Proof of concept</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/P028152/1</gtr:fundingRef><gtr:id>0D654717-1B0E-4972-A334-FCA5D63C5AA7</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC DTP summer studentship</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>71B42B64-0C78-4696-92DA-20B5D5447B15</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Re-engineered carbohydrate-binding proteins and virus-like particles have been prepared and used as cross-linking agents to prepare artificial tissues.
Reengineered bacterial toxins have been used to deliver nanoparticles into motor neurones</gtr:description><gtr:exploitationPathways>potential applications in drug delivery and tissue engineering</gtr:exploitationPathways><gtr:id>5E41E657-56BE-441F-8ED9-0CE64E713172</gtr:id><gtr:sectors><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FC6D0141-4359-4A76-8629-49F635119293"><gtr:id>FC6D0141-4359-4A76-8629-49F635119293</gtr:id><gtr:title>Compact, Polyvalent Mannose Quantum Dots as Sensitive, Ratiometric FRET Probes for Multivalent Protein-Ligand Interactions.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2585257962f19c804855e5920219ec8c"><gtr:id>2585257962f19c804855e5920219ec8c</gtr:id><gtr:otherNames>Guo Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/05DA5F0B-BA1B-4E71-B882-C5BDF2C00988"><gtr:id>05DA5F0B-BA1B-4E71-B882-C5BDF2C00988</gtr:id><gtr:title>Confirmation of a Protein-Protein Interaction in the Pantothenate Biosynthetic Pathway by Using Sortase-Mediated Labelling.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/980439cb0a80fbc1968804b914f207e0"><gtr:id>980439cb0a80fbc1968804b914f207e0</gtr:id><gtr:otherNames>Morrison PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A8CD6C15-8B96-4830-9B93-541A449D2778"><gtr:id>A8CD6C15-8B96-4830-9B93-541A449D2778</gtr:id><gtr:title>Compact, Polyvalent Mannose Quantum Dots as Sensitive, Ratiometric FRET Probes for Multivalent Protein-Ligand Interactions.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2585257962f19c804855e5920219ec8c"><gtr:id>2585257962f19c804855e5920219ec8c</gtr:id><gtr:otherNames>Guo Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0044-8249</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/M005666/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>8A1414BC-05E5-4D38-BDC1-A953EE4AF4E1</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Protein chemistry</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>